EUVIMEDEUVIMED entdecken
Crossref

Risk factors for failure following debridement, antibiotics, and implant retention (DAIR) in early periprosthetic joint infection after primary total hip arthroplasty

Roni Serra Campos, Amanda S Cavalcanti iD, Helano Jader Batista de Almeida, Jamila Alessandra Perini, Marco Bernardo Cury Fernandes, Juliana Arruda de Matos

HIP International · 2026-11 · 36 (6) · 940-949

DOI: 10.1177/11207000261459970 ↗

Kurz gefasst

Fachartikel in der Zeitschrift HIP International, online erschienen am 11.08.2026. Verfasst von Roni Serra Campos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Master Program in Musculoskeletal Sciences, National Institute of Traumatology and Orthopedics, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Prosthesis-Related Infections, Arthroplasty, Replacement, Hip, Debridement, Anti-Bacterial Agents. Die Arbeit nennt 37 Literaturangaben. Gefördert von: Fundaçăo Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

In the event of early or haematogenous periprosthetic joint infection (PJI), the preferred treatment is debridement, antibiotics, and implant retention (DAIR), with reported cure rates ranging from 60% to 80%. Nevertheless, the performance of this surgical strategy and the factors associated with poorer outcomes remain unknown in the Brazilian population. This study aims to evaluate the effectiveness of DAIR in early PJI following total hip arthroplasty (THA) and identify factors linked to unfavourable clinical outcomes.

Methods

This is a retrospective cohort study of patients who underwent primary THA between January 2011 and December 2017, developed early PJI, and were treated with DAIR with a minimum follow-up of 1 year. An unfavourable outcome was defined as infection persistence, recrudescence, recurrence, or the need for revision surgery.

Results

A total of 83 hips were included in the study, with a DAIR success rate of 72.3%. Staphylococcus aureus was the most frequently identified pathogen (59.7%), and no pathogen-related factors were associated with outcomes. Patient-related independent risk factors for unfavourable outcome included pre-DAIR haemoglobin ⩽ 10 g/dL (OR [95% CI] = 6.26, 1.63–24.08; p = 0.008) while a lower Charlson Comorbidity Index (CCI), a validated score that quantifies patient comorbidity burden, ⩽1 (OR [95% CI] = 0.04, 0.00–0.32; p = 0.003) and primary osteoarthritis (OR [95% CI] = 0.23, 0.06–0.95; p = 0.042) were protective. A procedure-related factor associated with failure was primary and THA surgical time ⩾180 minutes (OR [95% CI] = 10.15, 2.54–40.56; p = 0.001).

Conclusions

In this population, prognostic factors associated with DAIR outcomes were related to patient characteristics and features of the index procedure rather than to antibiotic therapy or DAIR itself. These findings may help refine patient selection for DAIR and highlight potentially modifiable factors – such as preoperative anaemia, that could reduce the risk of treatment failure following THA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prosthesis-Related InfectionsArthroplasty, Replacement, HipDebridementAnti-Bacterial AgentsHip ProsthesisHumansFemaleRetrospective StudiesMaleRisk FactorsAgedMiddle AgedTreatment FailureReoperationProsthesis RetentionCohort StudiesBrazil

Stichwörter der Autor:innen

ArthroplastyDebridement.HipProsthesis-Related InfectionsReplacement

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Master Program in Musculoskeletal Sciences, National Institute of Traumatology and Orthopedics, Rio de Janeiro, Brazil.
  • Center for Specialized Hip Care, National Institute of Traumatology and Orthopedics, Rio de Janeiro, Brazil.
  • Research Division, National Institute of Traumatology and Orthopedics, Rio de Janeiro, Brazil.
  • Research Laboratory of Pharmaceutical Sciences (LAPESF), Rio de Janeiro State University, Rio de Janeiro, Brazil.
  • Hospital Infection Control Committee, National Institute of Traumatology and Orthopedics, Rio de Janeiro, Brazil.

ORCID-Profile: Amanda S Cavalcanti

Förderung

  • Fundaçăo Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Zitieren

APA

Campos, R. S., Cavalcanti, A. S., Jader Batista de Almeida, H., Perini, J. A., Fernandes, M. B. C., & Arruda de Matos, J. (2026). Risk factors for failure following debridement, antibiotics, and implant retention (DAIR) in early periprosthetic joint infection after primary total hip arthroplasty. HIP International, 36(6), 940-949. https://doi.org/10.1177/11207000261459970

Vancouver

Campos RS, Cavalcanti AS, Jader Batista de Almeida H, Perini JA, Fernandes MBC, Arruda de Matos J. Risk factors for failure following debridement, antibiotics, and implant retention (DAIR) in early periprosthetic joint infection after primary total hip arthroplasty. HIP International. 2026;36(6):940-949. doi:10.1177/11207000261459970

BibTeX
@article{Campos2026,
  author = {Campos, Roni Serra and Cavalcanti, Amanda S and Jader Batista de Almeida, Helano and Perini, Jamila Alessandra and Fernandes, Marco Bernardo Cury and Arruda de Matos, Juliana},
  title = {Risk factors for failure following debridement, antibiotics, and implant retention (DAIR) in early periprosthetic joint infection after primary total hip arthroplasty},
  journal = {HIP International},
  year = {2026},
  volume = {36},
  number = {6},
  pages = {940--949},
  doi = {10.1177/11207000261459970}
}
Kostenlos starten →